Source FDA Certified Larotrectinib Sulfate for Oncology Research

FDA Certified Larotrectinib Sulfate Sourcing Guide

Procuring FDA certified Larotrectinib Sulfate requires a rigorous approach to verifying the chemical identity and regulatory standing of the supplier. Buyers must distinguish between the base compound and the sulfate salt form, as the latter is the specific active pharmaceutical ingredient often required for oncology formulations. The observed market data indicates that suppliers in Hangzhou, China, frequently list this material with CAS numbers such as 1223405-08-0, which is critical for ensuring the correct molecular structure is delivered.

Verification of the certification status is the primary hurdle in this sourcing channel, as listings often claim compliance with BP, USP, ISO, and GMP standards simultaneously. A buyer must confirm that the specific batch documentation explicitly references FDA acceptance or registration, rather than relying on general quality certifications like HSE or ISO alone. This distinction ensures that the material meets the stringent regulatory requirements necessary for clinical trials or commercial pharmaceutical manufacturing in regulated markets.

Product Scope and Observed Listing Signals

The product listings for Larotrectinib Sulfate typically describe the material as a white to off-white solid powder or crystalline substance, with some variations noting a pinkish-yellow hue depending on the specific grade or batch history. Buyers should expect to see physical descriptions ranging from standard white crystalline powder to off-white solids, which aligns with the typical appearance of high-purity organic salts used in therapeutic applications. These visual characteristics serve as the first line of defense against counterfeit or degraded materials during the initial inspection phase.

Commercial listings often present a wide range of packaging options, including bottles, bags, and drums, with specific weights like 25kg per drum or 1kg per bag being common. The observed data suggests that customization is frequently available, allowing buyers to request specific packaging configurations such as foil bags or cardboard drums to suit their logistics needs. However, the presence of "Customer Required" packing options alongside standard industrial drums indicates that buyers must clearly define their packaging requirements early to avoid mismatches in the final delivery.

Technical Specifications to Verify

Technical verification must focus on the molecular weight and purity assays, which are critical for ensuring the efficacy of the Larotrectinib Sulfate in drug formulations. The observed specifications list a molecular weight of 355.37 and purity levels exceeding 99%, which are standard benchmarks for high-grade pharmaceutical intermediates. Buyers should insist on seeing assay results that confirm the material meets or exceeds these thresholds, as deviations can significantly impact the stability and potency of the final medicinal product.

Analytical testing methods such as HPLC and UV spectroscopy are standard for confirming the identity and purity of the compound, with loss on drying typically capped at 1.0% or less. The data indicates that identification is often performed via HPLC or IR methods, providing a robust framework for quality assurance. Procurement teams must ensure that the supplier's test reports utilize these specific methodologies to validate the chemical structure and confirm that the material is non-volatile and suitable for the intended pharmaceutical application.

Compliance and Safety Documentation

Compliance documentation for Larotrectinib Sulfate must include a comprehensive Certificate of Analysis that aligns with the claimed certifications such as FDA, GMP, and USP. While some listings mention BP and ISO HSE certifications, the primary focus for FDA-regulated markets is the availability of documentation that proves the material meets the specific regulatory standards of the destination country. Buyers should request full traceability records that link the batch number to the raw materials and manufacturing processes used to produce the final salt form.

Safety data sheets and storage requirements are equally critical, as the material must be stored in a cool, dry place to maintain its shelf life of two years. The observed product attributes indicate that the substance is an ammonium organic salt, which necessitates careful handling to prevent degradation or contamination. Procurement contracts should explicitly state the storage conditions and handling procedures required to preserve the integrity of the product from the point of manufacture to the final point of use.

Cost Drivers and Commercial Terms

Cost drivers for Larotrectinib Sulfate are heavily influenced by the purity grade, certification status, and the specific packaging requirements requested by the buyer. The observed price range of 0.1 to 150 USD suggests a significant variance based on the quantity ordered and the level of regulatory compliance provided. Buyers must understand that higher costs are often associated with materials that carry specific FDA or GMP certifications, which require more rigorous quality control processes and documentation.

Commercial terms regarding minimum order quantities and shipping methods also play a pivotal role in the total cost of ownership. The data shows MOQs ranging from 1 to 100 units, with shipping options including express carriers like UPS, FedEx, and TNT. Buyers should negotiate terms that balance the need for small initial batches with the cost efficiency of larger orders, while ensuring that the chosen shipping method aligns with the stability requirements of the pharmaceutical product during transit.

Supplier Qualification and Quality Control

Supplier qualification for this specialized chemical requires a deep dive into their manufacturing capabilities and quality control systems. The observed listings indicate that suppliers are located in Hangzhou, China, and offer customization services, but buyers must verify that these facilities maintain the necessary GMP standards for pharmaceutical production. It is essential to audit the supplier's quality management system to ensure they can consistently produce material that meets the strict purity and identity specifications required for oncology drugs.

Quality control protocols must include rigorous testing for identity, assay, and impurities, with specific attention paid to the loss on drying and identification by HPLC or IR. The data suggests that suppliers often provide test methods like HPLC and UV, which are industry standards for verifying the chemical composition. Buyers should require that the supplier's internal QC processes are documented and that they are willing to share batch-specific test results before finalizing any purchase agreement.

Long-Term Procurement Checks

Long-term procurement strategies for Larotrectinib Sulfate must include regular re-verification of the supplier's certification status and the consistency of the product quality over time. As regulatory landscapes evolve, suppliers must demonstrate their ability to maintain compliance with changing FDA and international standards without compromising the supply chain. Buyers should establish a schedule for periodic audits and quality reviews to ensure that the material continues to meet the required specifications for the duration of the product lifecycle.

Supply chain resilience is another critical factor, as the availability of Larotrectinib Sulfate can be subject to fluctuations in raw material supply and manufacturing capacity. Buyers should develop contingency plans that include alternative suppliers or backup inventory strategies to mitigate the risk of shortages. The observed data indicates that while customization is available, relying on a single source for such a critical pharmaceutical ingredient poses a significant risk to continuous production and patient safety.